Quiz: 2017 ACC/AHA/HFSA Update to 2013 HF GuidelinesTest your recall of the most recent amendments to the heart failure guidelines on prevention, treatment of hypertension, and comorbidities.
Methamphetamine-associated PAH: First Prospective Cohort StudyMethamphetamine abuse is on a steady rise in the US. A new study highlights the nature and dangers of Meth-PAH.
Hellenic Heart Failure Study: Impact of Mediterranean Diet on Recurrent ACSResults of this study suggest a role for the anti-inflammatory diet in secondary prevention.
Blood Pressure and Target Organ Damage: The HeartThe spectrum of hypertensive heart disease is broad. Try these 2 questions to help sharpen your focus on points along the disease continuum.
Toward Improved Risk Stratification in Pulmonary Arterial HypertensionA new study supports the utility of pulmonary arterial proportional pulse pressure to predict 5-year mortality in patients with PAH.
How Dangerous is Digoxin in AF?Results of a post-hoc analysis of the ENGAGE-AF TIMI 48 trial show the answer could depend on a heart failure Dx.
Quiz: Is Beta-blockade Safe in COPD Patients?Beta-blockers may decrease FEV1 but have shown remarkable benefits in COPD patients. True or False?
Metformin Linked to Decreased Mortality in CKD, CHF, and Liver DiseaseWhile the strength of evidence for this "protective" effect is low, observers support further comparative effectiveness research in these patient groups.
Blood Pressure Paradox: Hypertension Associated with Survival in T2D and HFPatients with comorbid T2D and heart failure may have a "distinct pathophysiology of the heart" say authors of a new study.
SGLT2 Inhibitors Improve HF, Survival in Clinical T2D PopulationFindings from the REAL-CVD outcomes study reported at ACC.17 suggest class effect for cardioprotection.